UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts

Leukemia, 2017-03, Vol.31 (3), p.720-727

2017

Volltextzugriff (PDF)

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Leukemia, 2018-04, Vol.32 (4), p.1043-1047

2018

Volltextzugriff (PDF)

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications

Leukemia, 2009-10, Vol.23 (10), p.1731-1743

2009

Volltextzugriff (PDF)

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype

Leukemia, 2015-05, Vol.29 (5), p.1177-1185

2015

Volltextzugriff (PDF)

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e467-e467

2016

Volltextzugriff (PDF)

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

Haematologica (Roma), 2007-04, Vol.92 (4), p.519-532

2007

Volltextzugriff (PDF)

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas

Leukemia, 2007-07, Vol.21 (7), p.1566-1570

2007

Volltextzugriff (PDF)

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

Leukemia, 2017-12

2017

Volltextzugriff (PDF)

Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb

Leukemia, 2011-03, Vol.25 (3), p.506-514

2011

Volltextzugriff (PDF)

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture

Leukemia, 2013-09, Vol.27 (9), p.1820-1825

2013

Volltextzugriff (PDF)

P849: DEPLETION OF DIS3 IN MULTIPLE MYELOMA LEADS TO PERTURBATION IN RNA METABOLISM, CELL CYCLE PROGRESSION AND MITOTIC CHECKPOINT

HemaSphere, 2022-06, Vol.6 (Suppl), p.743-744

2022

Volltextzugriff (PDF)

P875: ACTIVATION OF LNCRNA NEAT1 LEADS TO SURVIVAL ADVANTAGE OF MULTIPLE MYELOMA CELLS BY SUPPORTING A REGULATORY LOOP WITH DNA REPAIR PROTEINS: RATIONAL BASES FOR NEAT1 THERAPEUTIC TARGETING IN THE DISEASE

HemaSphere, 2022-06, Vol.6 (Suppl), p.768-769

2022

Volltextzugriff (PDF)

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF

Leukemia, 2009-03, Vol.23 (3), p.501-509

2009

Volltextzugriff (PDF)

Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin

Leukemia, 2005-10, Vol.19 (10), p.1760-1767

2005

Volltextzugriff (PDF)

In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin ( ) mutations and is restricted to AML

Leukemia, 2008-06, Vol.22 (6), p.1285-1289

2008

Volltextzugriff (PDF)

Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation

Leukemia, 2007-05, Vol.21 (5), p.1099-1103

2007

Volltextzugriff (PDF)

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Blood cancer journal (New York), 2017-03, Vol.7 (3), p.e544-e544

2017

Volltextzugriff (PDF)

Next Generation Sequencing in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e2-e3

2015

Volltextzugriff (PDF)

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Blood cancer journal (New York), 2016-11, Vol.6 (11), p.e491-e491

2016

Volltextzugriff (PDF)

Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A Review

JAMA oncology, 2020-03, Vol.6 (3), p.425

2020

Volltextzugriff (PDF)

Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif

Leukemia, 2007-09, Vol.21 (9), p.2052-2054

2007

Volltextzugriff (PDF)

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia

Leukemia, 2008-12, Vol.22 (12), p.2285-2288

2008

Volltextzugriff (PDF)

Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML

Leukemia, 2008, Vol.22 (1), p.195-198

2008

Volltextzugriff (PDF)

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML

Leukemia, 2006-02, Vol.20 (2), p.368-371

2006

Volltextzugriff (PDF)

Response to SARS‐CoV‐2 vaccination and antibodies persistence in multiple myeloma patients

Hematological oncology, 2023-02, Vol.41 (1), p.210-212

2023

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(206)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture

P849: DEPLETION OF DIS3 IN MULTIPLE MYELOMA LEADS TO PERTURBATION IN RNA METABOLISM, CELL CYCLE PROGRESSION AND MITOTIC CHECKPOINT

P875: ACTIVATION OF LNCRNA NEAT1 LEADS TO SURVIVAL ADVANTAGE OF MULTIPLE MYELOMA CELLS BY SUPPORTING A REGULATORY LOOP WITH DNA REPAIR PROTEINS: RATIONAL BASES FOR NEAT1 THERAPEUTIC TARGETING IN THE DISEASE

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF

Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin

In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin ( ) mutations and is restricted to AML

Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Next Generation Sequencing in Multiple Myeloma

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A Review

Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia

Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML

Response to SARS‐CoV‐2 vaccination and antibodies persistence in multiple myeloma patients

Suchergebnisse filtern